Drug:
Reaction: INJECTION SITE PAIN
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26533484 |
US |
41 | 2 |
Pain, Product preparation error, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, DESONIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 402 | 26533486 |
US |
50 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 403 | 26533499 |
US |
9 | 2 |
Anxiety, Stress, Eczema, Rash, Pruritus, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 404 | 26533502 |
US |
33 | 2 |
Increased appetite, Eczema, Injection site pain, Intentional product misuse, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 405 | 26533883 |
US |
1 | |
Injection site haemorrhage, Injection site pain, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 406 | 26533908 |
US |
41 | 2 |
Lipoatrophy, Injection site pruritus, Injection site nodule, Injection site urticaria, Skin discolouration, Rash macular, Skin disorder, Immediate post-injection reaction, Hyperaesthesia, Injection site pain, Injection site erythema, Stress, |
||||
GLATIRAMER ACETATE, |
||||
| 407 | 26533975 |
CA |
72 | 2 |
Candida infection, Injection site pain, Mouth ulceration, Myalgia, Psoriatic arthropathy, Drug ineffective, Off label use, Asthenia, Eye operation, Gingival pain, Mobility decreased, Rhinorrhoea, |
||||
METHOTREXATE, METHOTREXATE SODIUM, BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, CELECOXIB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, MAGNESIUM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 408 | 26534011 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, SOMAPACITAN-BECO, CANNABIDIOL, VIGABATRIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, DIVALPROEX SODIUM, DESMOPRESSIN ACETATE, LEVOTHYROXINE SODIUM, MELATONIN, CALCIUM, MAGNESIUM, POLYETHYLENE GLYCOL 3350, CANNABIDIOL, ESOMEPRAZOLE MAGNESIUM, CELECOXIB, SENNOSIDES, SENNA LEAF, SENNA, LACOSAMIDE, CLONAZEPAM, HYDROCORTISONE, DIVALPROEX SODIUM, LONAPEGSOMATROPIN-TCGD, |
||||
| 409 | 26534116 |
CA |
49 | 1 |
Asthenia, Blood glucose increased, Blood pressure increased, Blood pressure systolic increased, Body temperature increased, Cardiac disorder, Chest pain, Depression, Fatigue, Gait disturbance, Hepatic lesion, Injection site haemorrhage, Injection site mass, Injection site pain, Lethargy, Needle issue, Neoplasm progression, Post procedural infection, Skin lesion, Syringe issue, Tachycardia, Underdose, Weight decreased, Inappropriate schedule of product administration, Drug ineffective, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, AMLODIPINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 410 | 26534147 |
US |
1 | |
Gait disturbance, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 411 | 26534160 |
US |
42 | 2 |
Haematochezia, Hepatic pain, Abdominal pain upper, Abdominal pain, Injection site pain, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 412 | 26534180 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 413 | 26534191 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 414 | 26534218 |
US |
28 | 2 |
Injection site pain, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 415 | 26534283 |
US |
28 | 2 |
Injection site swelling, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 416 | 26534357 |
US |
9 | 2 |
Injection site mass, Injection site pain, |
||||
DUPILUMAB, |
||||
| 417 | 26534394 |
US |
51 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 418 | 26534430 |
US |
||
Injection site pain, |
||||
ATEZOLIZUMAB AND HYALURONIDASE-TQJS, |
||||
| 419 | 26534463 |
US |
1 | |
Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, TIRZEPATIDE, EMPAGLIFLOZIN, ERGOCALCIFEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUOXETINE HYDROCHLORIDE, CARVEDILOL, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 420 | 26534494 |
US |
23 | 2 |
Injection site pain, Injection site erythema, Injection site swelling, Injection site pruritus, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 421 | 26534544 |
2 | ||
Injection site pain, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 422 | 26534558 |
US |
71 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 423 | 26534608 |
US |
25 | 1 |
Injection site pain, Conjunctivitis, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 424 | 26534683 |
CA |
43 | 2 |
Syncope, Injection site pain, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CELECOXIB, ESCITALOPRAM OXALATE, ESCITALOPRAM, |
||||
| 425 | 26534842 |
US |
19 | 2 |
Injection site pain, |
||||
DUPILUMAB, LORATADINE, LORATADINE TABLET, FEXOFENADINE HYDROCHLORIDE, |
||||
| 426 | 26534849 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 427 | 26534861 |
US |
65 | 2 |
Injection site pain, Oral herpes, |
||||
DUPILUMAB, FUROSEMIDE, PANTOPRAZOLE SODIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, CARVEDILOL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FAMOTIDINE, GABAPENTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, EMPAGLIFLOZIN, ORAL SEMAGLUTIDE, SPIRONOLACTONE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, ESTRADIOL, ERGOCALCIFEROL, |
||||
| 428 | 26534911 |
US |
15 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 429 | 26534913 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, GABAPENTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, OMALIZUMAB, ADALIMUMAB, CALCIUM, |
||||
| 430 | 26535018 |
US |
51 | 2 |
Incorrect dose administered, Injection site pain, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 431 | 26535094 |
US |
6 | 1 |
Therapeutic response decreased, Injection site pain, |
||||
DUPILUMAB, |
||||
| 432 | 26535100 |
US |
35 | 1 |
Abdominal rigidity, Injection site pain, Abdominal distension, |
||||
TESAMORELIN, |
||||
| 433 | 26535102 |
US |
82 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 434 | 26535195 |
US |
67 | 1 |
Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 435 | 26535429 |
US |
42 | 2 |
Injection site pain, Wrong technique in product usage process, |
||||
| 436 | 26535449 |
1 | ||
Injection site pain, Injection site mass, Swelling face, |
||||
REPOSITORY CORTICOTROPIN, PREDNISONE, |
||||
| 437 | 26535540 |
US |
74 | 2 |
Injection site pain, Injection site haemorrhage, Product preparation error, |
||||
| 438 | 26535541 |
US |
84 | 2 |
Pruritus, Erythema, Urticaria, Injection site pain, |
||||
| 439 | 26535688 |
US |
32 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, RIMEGEPANT SULFATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 440 | 26535694 |
57 | ||
Injection site pain, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 441 | 26535706 |
US |
69 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 442 | 26535707 |
US |
39 | 1 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 443 | 26535709 |
US |
44 | 2 |
Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, SUMATRIPTAN, |
||||
| 444 | 26537847 |
35 | 2 | |
Injection site pain, Injection site haemorrhage, Product leakage, |
||||
ADALIMUMAB, |
||||
| 445 | 26526795 |
US |
61 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 446 | 26526878 |
US |
68 | 2 |
Rotator cuff repair, Arthropathy, Injection site pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 447 | 26527383 |
US |
||
Back pain, Blood urine present, Injection site pain, Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 448 | 26527387 |
|||
Injection site pain, Device malfunction, Off label use, |
||||
BIMEKIZUMAB, |
||||
| 449 | 26527714 |
US |
70 | 2 |
Limb injury, Foot fracture, Sinusitis, Head discomfort, Sinus congestion, Oropharyngeal pain, Pruritus, Product dose omission issue, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 450 | 26527798 |
US |
40 | 2 |
Injection site pain, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 451 | 26528101 |
US |
52 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, |
||||
| 452 | 26528165 |
US |
60 | 2 |
Extra dose administered, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 453 | 26528215 |
63 | ||
Psoriatic arthropathy, Abdominal pain, Candida infection, Injection site erythema, Dysphagia, Oropharyngeal discomfort, Eating disorder, Erythema, Skin discolouration, Injection site pain, Skin plaque, Weight decreased, Lichen planus, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, METOPROLOL TARTRATE, METOPROLOL, CETIRIZINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SEMAGLUTIDE, ORAL SEMAGLUTIDE, ERGOCALCIFEROL, |
||||
| 454 | 26528556 |
US |
||
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 455 | 26528635 |
US |
49 | 2 |
Injection site pain, |
||||
OCRELIZUMAB, OCRELIZUMAB, |
||||
| 456 | 26528674 |
US |
57 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 457 | 26528975 |
US |
65 | 2 |
Injection site pain, Skin reaction, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 458 | 26528977 |
63 | ||
Cystitis, Sinusitis, Injection site discolouration, Injection site pain, Product temperature excursion issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 459 | 26529088 |
US |
52 | 2 |
Incorrect dose administered, Injection site discomfort, Injection site bruising, Injection site haemorrhage, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 460 | 26529295 |
BR |
1 | |
Dementia Alzheimer^s type, Injection site pain, Product dose omission issue, |
||||
DULAGLUTIDE, |
||||
| 461 | 26529611 |
US |
74 | 1 |
Cataract, Injection site pain, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, ALLOPURINOL, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUTICASONE PROPIONATE, |
||||
| 462 | 26529848 |
US |
27 | |
Injection site pain, Nausea, |
||||
TIRZEPATIDE, |
||||
| 463 | 26529859 |
US |
60 | 2 |
Gastrointestinal haemorrhage, Vitamin B12 decreased, Haemoglobin decreased, Injection site pain, Dermatitis atopic, Rash macular, Discomfort, Sleep disorder due to a general medical condition, Off label use, |
||||
DUPILUMAB, DUPILUMAB, MELOXICAM, PANTOPRAZOLE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, NIFEDIPINE, |
||||
| 464 | 26530089 |
47 | ||
Abdominal discomfort, Musculoskeletal stiffness, Pain, Insomnia, Injection site pain, Pustule, Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 465 | 26530110 |
28 | 2 | |
Nausea, Pruritus, Insomnia, Injection site pain, Injection site erythema, Injection site rash, Injection site swelling, Injection site pruritus, Injection site bruising, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 466 | 26530125 |
2 | ||
Injection site pain, |
||||
| 467 | 26530250 |
US |
62 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 468 | 26530261 |
US |
73 | 2 |
Cerebrovascular accident, Injection site pain, Inflammation, |
||||
ANAKINRA, |
||||
| 469 | 26530463 |
KR |
1 | |
Injection site pain, |
||||
SOMATROPIN, |
||||
| 470 | 26530527 |
44 | 2 | |
Cellulitis, Injection site urticaria, Injection site warmth, Injection site swelling, Injection site pain, Diarrhoea, Headache, Injection site erythema, Injection site rash, Injection site pruritus, |
||||
REPOSITORY CORTICOTROPIN, CETIRIZINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, FAMOTIDINE, |
||||
| 471 | 26530580 |
US |
2 | |
Injection site pain, Pain in extremity, |
||||
ADALIMUMAB, TOCILIZUMAB, |
||||
| 472 | 26530819 |
24 | ||
Injection site pain, |
||||
BIMEKIZUMAB, |
||||
| 473 | 26530875 |
US |
46 | 2 |
Burning sensation, Injection site pain, |
||||
IOHEXOL, |
||||
| 474 | 26530876 |
US |
49 | 1 |
Burning sensation, Dyspnoea, Erythema, Injection site pain, |
||||
IOHEXOL, |
||||
| 475 | 26530878 |
US |
49 | 1 |
Aphasia, Vertigo, Hyperhidrosis, Injection site hypoaesthesia, Injection site pain, |
||||
IOHEXOL, |
||||
| 476 | 26530895 |
US |
70 | 2 |
Injection site pain, |
||||
DULAGLUTIDE, |
||||
| 477 | 26530991 |
US |
64 | 1 |
Psoriatic arthropathy, Device difficult to use, Injection site pain, Injection site haemorrhage, Temporomandibular pain and dysfunction syndrome, Illness, Decreased immune responsiveness, Incorrect dose administered by device, Accidental exposure to product, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 478 | 26531029 |
US |
51 | 2 |
Injection site pain, Injection site haemorrhage, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 479 | 26522606 |
US |
61 | 2 |
Injection site pain, |
||||
GALCANEZUMAB-GNLM, |
||||
| 480 | 26522628 |
US |
1 | |
Injection site pain, |
||||
RISPERIDONE, |
||||
| 481 | 26522792 |
50 | ||
Injection site pain, Illness, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 482 | 26522822 |
43 | ||
Injection site pain, Product dose omission issue, Device issue, Accidental exposure to product, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 483 | 26522869 |
AU |
2 | |
Arthralgia, Balance disorder, Gait disturbance, Injection site pain, Pain, Pain in extremity, Paraesthesia, Device issue, Diarrhoea, Nausea, |
||||
COLCHICINE, ETANERCEPT, |
||||
| 484 | 26522985 |
JP |
73 | 1 |
Lymphoma, Injection site pain, |
||||
CABOTEGRAVIR SODIUM, RILPIVIRINE, |
||||
| 485 | 26523126 |
35 | ||
Injection site pain, |
||||
BIMEKIZUMAB, |
||||
| 486 | 26523174 |
US |
47 | 2 |
Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 487 | 26523294 |
US |
75 | 2 |
Extra dose administered, Injection site pain, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 488 | 26523369 |
74 | ||
Psoriasis, Injection site pain, Oropharyngeal pain, Fatigue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, ZOLPIDEM TARTRATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 489 | 26523380 |
US |
70 | 2 |
Injection site pain, Injection site irritation, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 490 | 26523466 |
US |
2 | |
Injection site pain, Injection site bruising, |
||||
TIRZEPATIDE, |
||||
| 491 | 26523735 |
41 | ||
Psoriatic arthropathy, Psoriasis, Injection site pain, Wound, Erythema, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 492 | 26523944 |
CN |
1 | |
Product label issue, Accidental exposure to product, Injection site pain, |
||||
GUSELKUMAB, |
||||
| 493 | 26524096 |
US |
54 | 1 |
Pruritus, Parosmia, Weight decreased, Injection site mass, Injection site bruising, Injection site haemorrhage, Injection site pain, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 494 | 26524346 |
GB |
2 | |
Hospitalisation, Injection site mass, Injection site erythema, Injection site pain, Injection site indentation, Drug ineffective, Product dose omission issue, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, |
||||
| 495 | 26524476 |
32 | ||
Oesophageal infection, Injection site pain, Gastrooesophageal reflux disease, Wrong technique in product usage process, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 496 | 26524477 |
US |
65 | 2 |
Nausea, Diarrhoea, Injection site erythema, Injection site mass, Injection site pruritus, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 497 | 26524478 |
US |
50 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 498 | 26524721 |
US |
||
Injection site abscess, Counterfeit product administered, Injection site pain, Suspected counterfeit product, |
||||
SOMATROPIN, |
||||
| 499 | 26524897 |
US |
64 | 2 |
Injection site discomfort, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 500 | 26525459 |
US |
||
Injection site pain, |
||||
TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28